Prevalence and Incidence of Mantle cell lymphoma
Mantle cell lymphoma: Rare Disease
Mantle cell lymphoma is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Mantle cell lymphoma, or a subtype of Mantle cell lymphoma,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Mantle cell lymphoma as a "rare disease".
More information about Mantle cell lymphoma is available from Orphanet
About prevalence and incidence statistics:
The term 'prevalence' of Mantle cell lymphoma usually refers to the estimated population
of people who are managing Mantle cell lymphoma at any given time.
The term 'incidence' of Mantle cell lymphoma refers to the annual diagnosis rate,
or the number of new cases of Mantle cell lymphoma diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.